Evaluating the Impact of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics
- Conditions
- Diabetes Mellitus
- Interventions
- Behavioral: Live diabetes coaching program
- Registration Number
- NCT03719911
- Lead Sponsor
- Welkin Health
- Brief Summary
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced using an mobile application and care management platform.
- Detailed Description
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced by integrating a participant-facing mobile application with the coaching platform. Blood glucose test results automatically populate the coaching platform, providing the CDE with information that may better support their coaching efforts.
The participants complete Diabetes Self Management Education (DSME) learning modules for the first 7-12 weeks. Following completion of the modules, the coach continues to provide support to the participant until 24 weeks after the participant's enrollment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
- Lives in the United States
- Speaks and understands English
- Has a Type 2 diabetes mellitus diagnosis
- Has a LifeScan Verio Flex blood glucose meter, which is connected to OneTouch Reveal ® app
- Has a verified A1c ≥ 8%
- Willing to participate in coaching program
- Uses a continuous glucose monitoring device
- Currently pregnant
- Unable to make lifestyle behavioral changes due to a cognitive or physical disability
- Has end stage renal disease (ESRD) diagnosis
- Is not able to read or understand English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Live diabetes coaching program Live diabetes coaching program Live diabetes coaching program
- Primary Outcome Measures
Name Time Method Change in Hemoglobin A1c A1c measured at baseline, at 12 weeks since study enrollment, and at 24 weeks since enrollment, which marks the participant's completion of the study Blood serum test to measure glucose control
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Welkin Health
🇺🇸San Francisco, California, United States